POLYMORPHISM OF ANGIOTENSIN-CONVERTING
ENZYME (rs4340) AND DIABETIC NEPHROPATHY IN
CAUCASIANS WITH TYPE 2 DIABETES MELLITUS Šeruga M, Makuc J,, Završnik M, Cilenšek I, Ekart R, Petrovič D M. Šeruga and J. Makuc contributed equally to this study. *Corresponding Author: Professor Dr. Daniel Petrovič, M.D., Ph.D., Institute of Histology and Embryology, Faculty of
Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia. Tel: +386-1-543-7360. Fax: +386-1-543-7361.
E-mail: daniel.petrovic@mf.uni-lj.si page: 29
|
REFERENCES
1. Ritz E, Orth SR. Nephropathy in patients with type
2 diabetes mellitus. N Engl J Med. 1999; 341(15):
1127-1133.
2. Conway BR, Maxwell AP. Genetics of diabetic nephropathy:
Are there clues to the understanding of
common kidney diseases? Nephron Clin Pract 2009;
112(4): 213-221.
3. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH,
Caramori ML, Zelmanovitz T. Diabetic nephropathy:
Diagnosis, prevention, and treatment. Diabetes Care.
2005; 28(1): 164-176.
4. Carpena MP, Rados DV, Sortica DA, deSouza BM, Reis
AF, Canani LH, et al. Genetics of diabetic nephropathy.
Arq Bras Endocrinol Metab. 2010; 54(3): 254-261.
5. Kato M, Natarajan R. Diabetic nephropathy-emerging
epigenetic mechanisms. Nat Rev Nephrol. 2014;
10(9): 517-530.
6. Bouchard J, Macedo E, Soroko S, Chertow GM, Himmelfarb
J, Ikizler TA, et al. Comparison of methods
for estimating glomerular filtration rate in critically
ill patients with acute kidney injury. Nephrol Dial
Transplant. 2010; 25(1): 102-107.
7. Evans TC, Capell P. Diabetic nephropathy. Clin Diabetes.
2000; 18(1). (http://journal.diabetes.org/clinical
diabetes/v18n12000/Pg7.htm.7)
8. Appel GB, Radhakrishnan J, Avram MM, DeFronzo
RA, Escobar-Jimenez F, Campos MM, et al.; RENAL
Study. Analysis of metabolic parameters as predictors
of risk in the renal study. Diabetes Care. 2003; 26(5):
1402-1407.
9. Yacoub R, Campbell KN. Inhibition of RAS in diabetic
nephropathy. Int J Nephrol Renovasc Dis. 2015;
8(1): 29-40.
10. Gnudi L, Goldsmith D. Renin angiotensin aldosterone
system (RAAS) inhibitors in the prevention of early
renal disease in diabetes. F1000 Med Rep. 2010; 2.
pii: 18. doi: 10.3410/M2-18.
11. Movva S, Alluri RV, Komandur S, Vattam K, Eppa
K, Mukkavali KK, et al. Relationship of angiotensin-
converting enzyme gene plymorphism with nephropathy
associated with type 2 diabetes mellitus
in Asian Indians. J Diabetes Complications. 2007;
21(4): 237-241.
12. Moon JY. Recent update of renin-angiotensin-aldosterone
system in the pathogenesis of hypertension.
Electrolyte Blood Press. 2013; 11(2): 41-45.
13. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao
YJ, et al. The association between angiotensin-converting
enzyme insertion/deletion gene variant and
risk of focal segmental glomerulosclerosis: A systematic
review and meta-analysis. J Renin Angiotensin
Aldosterone Syst. 2011; 12(4): 624-633.
14. Glenn KL, Du ZQ, Eisenmann JC, Rothschild MF.
An alternative method for genotyping of the ACE
I/D polymorphism. Mol Biol Rep. 2009; 36(6):
1305-1310.
15. Zhou TB, Yin SS, Qin YH. Association between angiotensin-
converting enzyme insertion/deletion gene
polymorphism and end-stage renal disease susceptibility.
J Renin Angiotensin Aldosterone Syst. 2014;
15(1): 22-31.
16. World Health Organisation, Part 1: Diagnosis and
Clasification of Diabetes Mellitus: Report of a WHO
consultation, In: Alwan A, King H. Definition, diagnosis
and classification of diabetes mellitus and its
complications. World Health Department of Noncommunicable
Disease Surveillance, Geneva, Switzerland,
1999.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection
of the insertion/deletion polymorphism of the
human angiotensin converting enzyme gene. Nucleic
Acids Res. 1992; 20(6): 1433.
18. Shlipak M. Diabetic nephropathy. Clinical Evidence
(Online), 2009,0606. Pii: 0606. Review.
PubMed PMID: 19445773. PubMed Central PMCID:
PMC290779.
19. Kumar R, Sharma RK, Agarwal S. Genetic predisposition
for development of nephropathy in type 2
diabetes mellitus. Biochem Genet. 2013; 51(11-12):
865-875.
20. Gohda T, Makita Y, Shike T, Kobayashi M, Funabiki
K, Haneda M, et al. Association of the DD genotype
and development of Japanese type 2 diabetic
nephropathy. Clin Nephrol. 2001; 56(6): 475-480.
21. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L.
Serum cystatin C-based formulas for prediction of
glomerular filtration rate in patients with chronic
kidney disese. Nephron Clin Pract. 2010; 114(2):
c118-c126.
22. Bevc S, Hojs R, Ekart R, Gorenjak M, Puklvec L.
Simple cystatin C formula compared to sophisticated
CKD-EPI formulas for estimation of glomerular filtration
rate in the elderly. Ther Apher Dial. 2011;
15(3): 261-268.
23. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha
C, Ramachandran A, et al. Association between
ACE gene polymorphism and diabetic nephropathy
in South Indian patients. JOP. 2001; 2(2): 83-87.
24. Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow
CC, et al. Prognostic effect of insertion/deletion polymorphism
of the ace gene on renal and cardiovascular
clinical outcomes in Chinese patients with type 2
diabetes. Diabetes Care. 2005; 28(2): 348-354.
25. Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis
of the relationship between ACE I/D gene polymorphism
and end-stage renal disease in patients with
diabetic nephropathy. Nephrology (Carlton). 2012;
17(5): 480-487.
26. Zhong W, Jiang Z, Zhou TB. Association between the
ACE I/D gene polymorphism and T2DN susceptibility:
The risk of T2DM developing into T2DN in the
Asian population. J Renin Angiotensin Aldosterone
Syst. 2015; 12(1): 1-9.
27. Al-Rubeaan K, Siddiqui K, Saeb AT, Nazir N, Al-
Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T
poly-morphisms are significantly associated with type
2 diabetes in Arab ethnicity: A meta-analysis. Gene.
2013; 520(2): 166-177.
28. Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois
Y, Ankotche A, et al.; DIABHYCAR Study Group;
DIAB2NEPHROGENE Study Group; SURDIAGENE
Study Group. Prognostic value of the insertion/
deletion polymorphism of the ACE gene in type
2 diabetic subjects: Results from the mon-insulindependent
diabetes, hypertension, microalbuminuria
or proteinuria, cardiovascular events, and ramipril
(DIABHYCAR), diabete de type 2, nephropathie et
genetique (DIAB2NEPHROGENE), and survie, diabete
de type 2 et genetique (SURDIAGENE) studies.
Diabetes Care. 2008; 31(9): 1847-1852.
29. Hadjadj S, Tarnow L, Forsblom C, Kazeem G, Marre
M, Groop PH, et al.; EURAGEDIC (European Rational
Approach for Genetics of Diabetic Complications)
Study Group. Association between angiotensinconverting
enzyme gene polymorphisms and diabetic
nephropathy: Case-control, haplotype, and familybased
study in three European populations. J Am Soc
Nephrol. 2007; 18(4): 1284-1291.
30. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau
G, Chatellier G, et al. Prognostic value of angiotensin-
I converting enzyme I/D polymorphism for
nephropathy in type 1 diabetes mellitus: A prospective
study. J Am Soc Nephrol. 2001; 12(3): 541-549.
31. Nikzamir A, Rashidi A, Esteghamati A, Nakh-javani
M, Golmohammadi T, Khalilzadeh O. The relationship
between ACE gene insertion/deletion polymorphism
and diabetic retinopathy in Iranian patients
with type 2 diabetes. Ophthalmic Genet. 2010; 31(3):
108-113.
32. Jayapalan JJ, Muniandy S, Chan SP. Null association
between ACE gene I/D polymorphism and diabetic
nephropathy among multiethnic Malaysian subjects.
Indian J Hum Genet. 2010; 16(2): 78-86.
33. Wang F, Fang Q, Yu N, Zhao D, Zhang Y, Wang J,
et al. Association between genetic polymorphism
of the angiotensin-converting enzyme and diabetic
nephropathy: A meta-analysis comprising 26,580 subjects.
J Renin Angiotensin Aldosterone Syst. 2012;
13(1): 161-174.
34. Wang M, Zhang X, Song X, Zou X, Wu W, Wang Y, et
al. Nodular glomerulosclerosis and renin angiotensin
system in Chinese patients with type 2 diabetes. Mol
Cell Endocrinol. 2016; 427(3):92-100.
|
|
|
|
|
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|